30 July 2025
Caledonian Holdings plc
("Caledonian Holdings" or "the Company")
Quarterly Shareholder Update
The Board of Caledonian Holdings plc (AIM:CHP), an AIM-quoted investing company focused on the financial services market, today provides a quarterly shareholder update for the quarter ended 30 June 2025.
In line with the Company's refreshed strategy to focus on opportunities within the broader financial services sector, the Board was pleased to complete a new cash investment of £750,000 into AlbaCo Limited during the quarter. This represents a meaningful step in rebalancing the portfolio towards businesses aligned with the Company's revised sector focus. At the same time, the Board continues to proactively engage with and manage the existing portfolio, including a number of strategic divestments during the period. The Company remains actively focused on identifying and building a pipeline of attractive new investment opportunities within the target sector.
The portfolio investment update follows for information:
Key numbers as at 30 June 2025
· The total value of the Company's assets (including cash) decreased by £153,000 during the quarter to £2,518,000 (31 March 2025: £2,761,000; 31 December 2024: £2,670,000).
· The fair value of the investment portfolio (excluding cash) rose to £2,092,000 (31 March 2025 - £1,774,000).
· During the quarter, a net profit of £29,000 was realised on investment disposals, and there was a net unrealised loss of £195,000 on listed investments.
· The Company's cash balance as at 30 June 2025 stood at £428,000 (31 March 2025 - £787,000).
· The subscription element for £273,000 of the Company's total fundraising of £1,100,000 earlier in the year, first announced in March 2025, completed in April 2025.
Changes in the investment portfolio during the quarter
The following table sets out the changes in the investment portfolio during the quarter ended 30 June 2025:
| |
Holdings at 31 March 2025 |
Quarter to 30 June 2025 |
Holdings at 30 June 2025 |
|||||
|
|
Fair value (£) |
Sales |
Acquisitions |
Unrealised profit (loss) |
No. of |
% of equity |
Fair value (£) |
|
|
|
Proceeds |
Profit (loss) |
||||||
| Shares |
|
|
|
|
|
|
|
|
| Listed in the UK |
|
|
|
|
|
|
|
|
| On the main market |
|
|
|
|
|
|
|
|
| R8 Capital Investments plc |
14,000 |
- |
- |
- |
- |
620,581 |
< 1 |
14,000 |
| On AIM |
|
|
|
|
|
|
|
|
| Northcoders Group plc |
366,000 |
- |
- |
- |
(212,000) |
307,499 |
4.3 |
154,000 |
| EnSilica plc |
97,000 |
33,000 |
(7,000) |
- |
(4,000) |
141,707 |
< 1 |
53,000 |
| Skillcast Group plc |
196,000 |
235,000 |
39,000 |
- |
- |
- |
< 1 |
- |
| Ethernity plc |
- |
|
- |
- |
- |
350,000 |
< 1 |
- |
| Finseta plc |
62,000 |
17,000 |
2,000 |
- |
- |
150,000 |
< 1 |
47,000 |
| On AQSE |
|
|
|
|
|
|
|
|
| TruSpine Technologies plc |
38,000 |
- |
- |
- |
55,000 |
6,000,000 |
3.9 |
93,000 |
| Igraine PLC |
84,000 |
- |
- |
- |
(18,000) |
23,928,080 |
27.7 |
66,000 |
| Global Connectivity plc |
11,000 |
- |
- |
- |
4,000 |
1,200,000 |
< 1 |
15,000 |
| |
868,000 |
285,000 |
34,000 |
- |
(175,000) |
|
|
442,000 |
| Listed overseas |
|
|
|
|
|
|
|
|
| On NASDAQ |
|
|
|
|
|
|
|
|
| Conduit Pharmaceuticals Inc |
6,000 |
1,000 |
(5,000) |
- |
- |
- |
|
- |
| |
|
|
|
|
|
|
|
|
| Unlisted |
|
|
|
|
|
|
|
|
| Community Social |
427,000 |
- |
- |
- |
- |
71,429 |
< 1 |
427,000 |
| Aeristech Limited |
- |
- |
- |
- |
- |
145,833 |
< 1 |
- |
| Tribe Technology Holdings Ltd |
23,000 |
- |
- |
- |
- |
3,125,000 |
1.3 |
23,000 |
| Albaco Limited |
- |
- |
- |
750,000 |
- |
750,000 |
|
750,000 |
| |
450,000 |
- |
- |
750,000 |
- |
|
|
1,200,000 |
|
|
|
|
|
|
|
|
|
|
| Convertible loan stock |
|
|
|
|
|
|
|
|
| Igraine PLC |
150,000 |
- |
- |
- |
- |
- |
- |
150,000 |
| Hamak Gold Limited |
300,000 |
- |
- |
- |
- |
- |
- |
300,000 |
| |
450,000 |
- |
- |
- |
- |
|
|
450,000 |
| |
|
|
|
|
|
|
|
|
| Total investments |
1,774,000 |
286,000 |
29,000 |
750,000 |
(175,000) |
|
|
2,092,000 |
| Cash |
787,000 |
|
|
|
|
|
|
428,000 |
| Other Debtors |
200,000 |
|
|
|
|
|
|
- |
| Total assets |
2,671,000 |
|
|
|
|
|
|
2,518,000 |
|
|
|
|
|
|
|
|
|
|
The figures contained within this quarterly investment update are taken from unaudited management information.
Investments traded on a recognised stock market are valued using the accounting policies outlined in the notes to the annual financial statements. Unlisted investments and other financial assets are stated at the values attributed to them in the audited balance sheet as at 31 March 2024, unless there has been a transaction since that date which suggests a materially different valuation.
For further information, please contact:
| Jim McColl, Executive Director Brent Fitzpatrick, Non-Executive Chairman |
Tel: +44 (0) 7950 389469 |
| Allenby Capital Limited (Nominated Adviser) |
Tel: +44 (0) 20 3328 5656 |
| Nick Athanas / Piers Shimwell
|
|
| Peterhouse Capital Limited (Broker) |
Tel: +44 (0) 20 7469 0930 |
| |
|
|
|
|
| |
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.